Human Genome Sciences is developing a drug, Albuferon, a combination of the human protein albumin and interferon.

FORBES: Magazine Article

Human Genome Sciences (nasdaq: HGSI - news - people ) is developing a drug, Albuferon, a combination of the human protein albumin and interferon.

FORBES: Saving Your Liver